The IMPROVE study--a multinational, observational study in type 2 diabetes: baseline characteristics from eight national cohorts.

@article{Valensi2008TheIS,
  title={The IMPROVE study--a multinational, observational study in type 2 diabetes: baseline characteristics from eight national cohorts.},
  author={Paul Valensi and Marian Benroubi and Vito Borz{\`i} and Janusz Gumprecht and Ryuzo Kawamori and Joseph A. Shaban and Siddharth G. Shah and Marina Shestakova and Yang Wenying},
  journal={International journal of clinical practice},
  year={2008},
  volume={62 11},
  pages={1809-19}
}
AIMS The IMPROVE study is a multinational, open-label, non-randomised, 26-week observational study assessing the safety and effectiveness of biphasic insulin aspart 30 (BIAsp 30) treatment in type 2 diabetes in routine clinical practice. The principal aims of this report were to characterise the baseline population and physicians' treatment decisions. METHODS Patients with type 2 diabetes who required insulin and whose physician had decided to initiate BIAsp 30 were eligible. At baseline… CONTINUE READING
37 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 37 extracted citations

Similar Papers

Loading similar papers…